Custom Index Systems’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215K Buy
234
+16
+7% +$16.2K 0.09% 237
2025
Q4
$234K Sell
218
-87
-29% -$83.2K 0.1% 221
2025
Q3
$233K Buy
+305
New +$227K 0.07% 247
2025
Q1
Sell
-277
Closed -$214K 316
2024
Q4
$214K Sell
277
-19
-6% -$15.7K 0.11% 231
2024
Q3
$262K Buy
296
+43
+17% +$38.7K 0.14% 202
2024
Q2
$229K Sell
253
-600
-70% -$480K 0.13% 216
2024
Q1
$664K Sell
853
-33
-4% -$23.5K 0.38% 58
2023
Q4
$516K Buy
+886
New +$517K 0.32% 74

Other funds holding LLY

Custom Index Systems's LLY Position: Q1 2026 in Review

Custom Index Systems increased its Eli Lilly (LLY) stake by 7.3% in Q1 2026, buying an estimated $16.2K and bringing the position to 234 shares worth $215K. The position accounts for 0.09% of the portfolio, ranked #237.

Custom Index Systems first reported a position in LLY in Q4 2023 and has held it in 8 quarters since. The position peaked at $664K in Q1 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Custom Index Systems held 234 shares of Eli Lilly worth $215K as of Q1 2026.
  • Custom Index Systems bought 16 Eli Lilly shares in Q1 2026, an estimated $16.2K.
  • Eli Lilly made up 0.09% of Custom Index Systems's portfolio in Q1 2026, its #237 holding.
  • Custom Index Systems first reported a position in Eli Lilly in Q4 2023 and has held it in 8 quarters since.
  • Custom Index Systems's Eli Lilly position peaked at $664K in Q1 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Custom Index Systems's 13F filing for Q1 2026, filed 29 Apr 2026.